Annual report for Gufic BioSciences Ltd. for FY-2023
29-05-2023
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Tuesday, May 30, 2023 at 4:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite enclosed herewith.23-05-2023
GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Annual Secretarial Compliance Report of the Company issued by M/ s. Manish Ghia & Associates, Practicing Company Secretaries, Mumbai, for the Financial Year ended March 31, 2023.23-05-2023
GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023 And Recommendation Of Final Dividend, If Any, For The Financial Year 2022-23
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve 1. The Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. 2. Recommend dividend, if any, for the Financial Year 2022-23, subject to approval of shareholders at their ensuing Annual General Meeting. Further in continuation to our disclosure on Closure of Trading Window dated March 30, 2023 and pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window in respect of dealing in the Equity Shares of the Company for all the Designated Persons of the Company along with their immediate relatives, shall continue to remain closed until 48 hours post declaration of the said financial results.22-05-2023
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30(6) read with Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that M/s. CRISIL Ratings Limited, a Credit Rating Agency, has revised (upgraded) its rating on various bank facilities availed by the Company which is attached herewith.08-05-2023
GUFIC BIOSCIENCES LTD. - 509079 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGUFIC BIOSCIENCES LTD. 2CIN NO.L24100MH1984PLC033519 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 200.30 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ami Shah Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Devkinandan Roonghta Designation: Chief Financial Officer EmailId: [email protected] Date: 25/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.25-04-2023
GUFIC BIOSCIENCES LTD. - 509079 - Compliances- Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 40(9) & 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith certificate received from M/s. Manish Ghia & Associates, Practicing Company Secretaries, Mumbai for the financial year ended March 31, 2023.17-04-2023
GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith certificate received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended March 31, 2023.11-04-2023
GUFIC BIOSCIENCES LTD. - 509079 - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2022 to March 31, 2023 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz. Link Intime India Private Limited, which is registered as Registrar and Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058.06-04-2023
GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions, the Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons and their immediate relatives from April 01, 2023 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ended March 31, 2023. The date of meeting of the Board of Directors to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2023 will be intimated in due course.30-03-2023